Whipplewood Advisors LLC Sells 218 Shares of Intuitive Surgical, Inc. $ISRG

Whipplewood Advisors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 310 shares of the medical equipment provider’s stock after selling 218 shares during the quarter. Whipplewood Advisors LLC’s holdings in Intuitive Surgical were worth $168,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Aaron Wealth Advisors LLC raised its position in Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the last quarter. Crown Wealth Group LLC raised its position in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after buying an additional 20 shares during the last quarter. FSM Wealth Advisors LLC raised its position in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after buying an additional 20 shares during the last quarter. CFO4Life Group LLC raised its position in Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC raised its position in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently commented on ISRG. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Rothschild & Co Redburn raised their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Wells Fargo & Company raised their target price on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $546.51 on Monday. The business has a 50-day moving average of $458.09 and a 200 day moving average of $497.11. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market cap of $195.91 billion, a P/E ratio of 72.29, a price-to-earnings-growth ratio of 5.02 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.